StemWave

StemWave is a medical technology company focused on non-invasive acoustic wave therapy aimed at activating the body's natural healing processes. Their flagship product, the StemWave acoustic wave therapy machine, utilizes advanced electrohydraulic technology and Cellular Response Technology (CRT) to deliver effective treatments in just 3 to 8 minutes. This FDA Class 1 cleared device can be operated by trained staff, making it accessible for various healthcare settings. In addition to their technology, StemWave offers comprehensive clinical and business training programs to support healthcare providers. These programs include marketing strategies to attract new patients and enhance practice growth. The company serves clinics, hospitals, and sports medicine organizations, promoting a cash-based treatment model that increases revenue and patient volume. With a presence in over 500 clinics and partnerships with notable athletic organizations, StemWave is recognized for its innovative approach to pain management. Headquartered in Massachusetts, the company has been rapidly expanding and was ranked the 227th fastest-growing privately held company in the U.S. in 2023.

• Employees 66
• Founded 2022